Insider Transactions in Q1 2025 at Ambac Financial Group Inc (AMBC)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 06
2025
|
Daniel Mc Ginnis Sr. MD & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,736
-26.74%
|
$60,624
$9.16 P/Share
|
|
Mar 06
2025
|
Daniel Mc Ginnis Sr. MD & COO |
BUY
Exercise of conversion of derivative security
|
Direct |
16,874
+40.11%
|
-
|
|
Mar 06
2025
|
David Barranco Senior Managing Director |
SELL
Payment of exercise price or tax liability
|
Direct |
7,379
-5.43%
|
$66,411
$9.16 P/Share
|
|
Mar 06
2025
|
David Barranco Senior Managing Director |
BUY
Grant, award, or other acquisition
|
Direct |
17,519
+11.43%
|
-
|
|
Mar 06
2025
|
Claude Le Blanc Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
10,809
-2.01%
|
$97,281
$9.16 P/Share
|
|
Mar 06
2025
|
Claude Le Blanc Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,809
+1.97%
|
-
|
|
Mar 06
2025
|
Stephen Michael Ksenak Sr. MD & General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
1,967
-1.63%
|
$17,703
$9.16 P/Share
|
|
Mar 06
2025
|
Stephen Michael Ksenak Sr. MD & General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
1,967
+1.63%
|
-
|
|
Mar 06
2025
|
Robert Bryan Eisman Sr. MD & CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,271
-1.81%
|
$11,439
$9.16 P/Share
|
|
Mar 06
2025
|
Robert Bryan Eisman Sr. MD & CAO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,271
+1.81%
|
-
|
|
Mar 06
2025
|
R Sharon Smith Exec VP & Chief Strategy Offr |
SELL
Payment of exercise price or tax liability
|
Direct |
2,154
-2.8%
|
$19,386
$9.16 P/Share
|
|
Mar 06
2025
|
R Sharon Smith Exec VP & Chief Strategy Offr |
BUY
Exercise of conversion of derivative security
|
Direct |
2,154
+2.73%
|
-
|
|
Mar 06
2025
|
David Trick Exec VP, CFO & Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,446
-1.54%
|
$22,014
$9.16 P/Share
|
|
Mar 06
2025
|
David Trick Exec VP, CFO & Treasurer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,446
+1.52%
|
-
|
|
Mar 03
2025
|
David Trick Exec VP, CFO & Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
201
-0.13%
|
$1,809
$9.3 P/Share
|
|
Mar 03
2025
|
David Trick Exec VP, CFO & Treasurer |
BUY
Exercise of conversion of derivative security
|
Direct |
201
+0.13%
|
-
|
|
Mar 03
2025
|
Daniel Mc Ginnis Sr. MD & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
300
-3.48%
|
$2,700
$9.3 P/Share
|
|
Mar 03
2025
|
Daniel Mc Ginnis Sr. MD & COO |
BUY
Exercise of conversion of derivative security
|
Direct |
300
+3.36%
|
-
|
|
Mar 03
2025
|
R Sharon Smith Exec VP & Chief Strategy Offr |
SELL
Payment of exercise price or tax liability
|
Direct |
532
-0.71%
|
$4,788
$9.3 P/Share
|
|
Mar 03
2025
|
R Sharon Smith Exec VP & Chief Strategy Offr |
BUY
Exercise of conversion of derivative security
|
Direct |
532
+0.7%
|
-
|
|
Mar 03
2025
|
Stephen Michael Ksenak Sr. MD & General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
400
-0.34%
|
$3,600
$9.3 P/Share
|
|
Mar 03
2025
|
Stephen Michael Ksenak Sr. MD & General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
400
+0.34%
|
-
|
|
Mar 03
2025
|
Claude Le Blanc Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
888
-0.17%
|
$7,992
$9.3 P/Share
|
|
Mar 03
2025
|
Claude Le Blanc Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
888
+0.17%
|
-
|
|
Mar 03
2025
|
David Barranco Senior Managing Director |
SELL
Payment of exercise price or tax liability
|
Direct |
2,099
-1.74%
|
$18,891
$9.3 P/Share
|
|
Mar 03
2025
|
David Barranco Senior Managing Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,214
+4.15%
|
-
|
|
Mar 03
2025
|
Robert Bryan Eisman Sr. MD & CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
212
-0.31%
|
$1,908
$9.3 P/Share
|
|
Mar 03
2025
|
Robert Bryan Eisman Sr. MD & CAO |
BUY
Exercise of conversion of derivative security
|
Direct |
212
+0.31%
|
-
|
|
Feb 28
2025
|
David Trick Exec VP, CFO & Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
663
-0.42%
|
$5,967
$9.71 P/Share
|
|
Feb 28
2025
|
David Trick Exec VP, CFO & Treasurer |
BUY
Exercise of conversion of derivative security
|
Direct |
663
+0.42%
|
-
|
|
Feb 28
2025
|
Daniel Mc Ginnis Sr. MD & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
330
-3.82%
|
$2,970
$9.71 P/Share
|
|
Feb 28
2025
|
Daniel Mc Ginnis Sr. MD & COO |
BUY
Exercise of conversion of derivative security
|
Direct |
330
+3.68%
|
-
|
|
Feb 28
2025
|
R Sharon Smith Exec VP & Chief Strategy Offr |
SELL
Payment of exercise price or tax liability
|
Direct |
641
-0.85%
|
$5,769
$9.71 P/Share
|
|
Feb 28
2025
|
R Sharon Smith Exec VP & Chief Strategy Offr |
BUY
Exercise of conversion of derivative security
|
Direct |
641
+0.84%
|
-
|
|
Feb 28
2025
|
Stephen Michael Ksenak Sr. MD & General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
582
-0.5%
|
$5,238
$9.71 P/Share
|
|
Feb 28
2025
|
Stephen Michael Ksenak Sr. MD & General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
582
+0.49%
|
-
|
|
Feb 28
2025
|
Claude Le Blanc Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,152
-0.22%
|
$10,368
$9.71 P/Share
|
|
Feb 28
2025
|
Claude Le Blanc Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,152
+0.22%
|
-
|
|
Feb 28
2025
|
David Barranco Senior Managing Director |
SELL
Payment of exercise price or tax liability
|
Direct |
2,370
-2.02%
|
$21,330
$9.71 P/Share
|
|
Feb 28
2025
|
David Barranco Senior Managing Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,725
+4.64%
|
-
|
|
Feb 28
2025
|
Robert Bryan Eisman Sr. MD & CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
233
-0.34%
|
$2,097
$9.71 P/Share
|
|
Feb 28
2025
|
Robert Bryan Eisman Sr. MD & CAO |
BUY
Exercise of conversion of derivative security
|
Direct |
233
+0.34%
|
-
|